Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1984 2
1985 1
1987 2
1988 1
1989 1
1991 1
1992 5
1993 1
1994 2
1995 2
1996 1
1998 2
1999 3
2001 1
2002 3
2003 4
2004 2
2005 2
2006 2
2007 2
2008 1
2009 2
2011 1
2013 1
2014 3
2015 3
2016 2
2017 1
2018 3
2019 3
2020 3
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Results by year
Filters applied: . Clear all
Page 1
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.
Cleland JGF, Ferreira JP, Mariottoni B, Pellicori P, Cuthbert J, Verdonschot JAJ, Petutschnigg J, Ahmed FZ, Cosmi F, Brunner La Rocca HP, Mamas MA, Clark AL, Edelmann F, Pieske B, Khan J, McDonald K, Rouet P, Staessen JA, Mujaj B, González A, Diez J, Hazebroek M, Heymans S, Latini R, Grojean S, Pizard A, Girerd N, Rossignol P, Collier TJ, Zannad F; HOMAGE Trial Committees and Investigators. Cleland JGF, et al. Among authors: rouet p. Eur Heart J. 2021 Feb 11;42(6):684-696. doi: 10.1093/eurheartj/ehaa758. Eur Heart J. 2021. PMID: 33215209 Free PMC article. Clinical Trial.
Dopamine beta-hydroxylase deficiency.
Senard JM, Rouet P. Senard JM, et al. Among authors: rouet p. Orphanet J Rare Dis. 2006 Mar 30;1:7. doi: 10.1186/1750-1172-1-7. Orphanet J Rare Dis. 2006. PMID: 16722595 Free PMC article. Review.
Insulin-like Growth Factor Binding Protein 2 predicts mortality risk in heart failure.
Barutaut M, Fournier P, Peacock WF, Evaristi MF, Caubère C, Turkieh A, Desmoulin F, Eurlings LWM, van Wijk S, Rocca HB, Butler J, Koukoui F, Dambrin C, Mazeres S, Le Page S, Delmas C, Galinier M, Jung C, Smih F, Rouet P. Barutaut M, et al. Among authors: rouet p. Int J Cardiol. 2020 Feb 1;300:245-251. doi: 10.1016/j.ijcard.2019.09.032. Epub 2019 Nov 18. Int J Cardiol. 2020. PMID: 31806281 Clinical Trial.
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF.
Ferreira JP, Verdonschot J, Wang P, Pizard A, Collier T, Ahmed FZ, Brunner-La-Rocca HP, Clark AL, Cosmi F, Cuthbert J, Díez J, Edelmann F, Girerd N, González A, Grojean S, Hazebroek M, Khan J, Latini R, Mamas MA, Mariottoni B, Mujaj B, Pellicori P, Petutschnigg J, Pieske B, Rossignol P, Rouet P, Staessen JA, Cleland JGF, Heymans S, Zannad F; HOMAGE (Heart Omics in AGEing) Consortium. Ferreira JP, et al. Among authors: rouet p. JACC Heart Fail. 2021 Apr;9(4):268-277. doi: 10.1016/j.jchf.2020.11.010. Epub 2021 Feb 3. JACC Heart Fail. 2021. PMID: 33549556 Free article. Clinical Trial.
Colloidal chemistry with patchy silica nanoparticles.
Rouet PE, Chomette C, Adumeau L, Duguet E, Ravaine S. Rouet PE, et al. Beilstein J Nanotechnol. 2018 Dec 6;9:2989-2998. doi: 10.3762/bjnano.9.278. eCollection 2018. Beilstein J Nanotechnol. 2018. PMID: 30591847 Free PMC article.
sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure.
Barutaut M, Fournier P, Peacock WF, Evaristi MF, Dambrin C, Caubère C, Koukoui F, Galinier M, Smih F, Rouet P. Barutaut M, et al. Among authors: rouet p. Acta Cardiol. 2020 Dec;75(8):739-747. doi: 10.1080/00015385.2019.1669847. Epub 2019 Sep 27. Acta Cardiol. 2020. PMID: 31560863
65 results